Ullman Reflects on Need for More FDA Enforcement

March 18, 2019 | Compliance Investigations & White Collar | Health Services

Marc Ullman was quoted in a NutraIngredients-USA article, “Indictment handed down in Florida over sale of SARMs, steroids.” Six people and two companies were charged by federal prosecutors for allegedly selling drugs unapproved by the FDA as supplements.

“Some of these people seem to think, ‘What’s the worst that can happen to me? A warning letter? No, you can get indicted. This should serve as a warning of the risk of ignoring warning letters and the risks of flouting the law by selling anabolic steroids and other likely illegal substances masquerading as dietary supplements” Ullman says.

“There should be more of this. Where is FDA’s own press release? Why isn’t this indictment the lead story on the news section on FDA’s home page? Secret enforcement is no deterrence,” Ullman added.

Click here to read the full article.

Share this article:

Related News


Get legal updates and news delivered to your inbox